Daria Gaut, MD, MSCR (@drdariagaut) 's Twitter Profile
Daria Gaut, MD, MSCR

@drdariagaut

Hematologist/Oncologist and Medical Director @Genentech. Alumni of @UCLAHealth and @ASH_Hematology Trainee Council.

ID: 1184306629711237120

calendar_today16-10-2019 03:14:46

96 Tweet

512 Followers

994 Following

Daria Gaut, MD, MSCR (@drdariagaut) 's Twitter Profile Photo

Check out my poster on #MRD in #AML. MRD conversion rate with consolidation chemotherapy in AML is low (~30%). We are in need of novel therapies for this high risk population. #ASH22 #ASHTrainee

Check out my poster on #MRD in #AML. MRD conversion rate with consolidation chemotherapy in AML is low (~30%). We are in need of novel therapies for this high risk population. #ASH22 #ASHTrainee
Daria Gaut, MD, MSCR (@drdariagaut) 's Twitter Profile Photo

Check out our second poster tonight on #MRD in #AML. Our goal is to give a therapy with an alternative mechanism of action to treat this chemoresistant population. #ASH22 #ASHTrainee #ASHAbstractAchievement

Check out our second poster tonight on #MRD in #AML. Our goal is to give a therapy with an alternative mechanism of action to treat this chemoresistant population. #ASH22 #ASHTrainee #ASHAbstractAchievement
ASH (@ash_hematology) 's Twitter Profile Photo

ASH's Trainee Council has added 4 ✨BRAND NEW✨ positions! Learn more about the ASH Trainee Council & how you can help build the future of #hematology 🩸🥼: loom.ly/iMEF2Y4 #ASHTrainee

Becky Zon, MD (@beckyzon) 's Twitter Profile Photo

So lucky to get to write this piece with Xu Han, PhD on the ASH Women in Hematology working group and all we’ve done! #SHEmatology #ASHtrainee Thankful to our WIH group leaders TamaraDunnMD and Ariela Marshall MD. Link here: hematology.org/education/trai…

Ajay Major, MD, MBA (@majorajay) 's Twitter Profile Photo

Our multicenter study of outcomes after checkpoint inhibitor therapy in the post-CAR-T setting is now Blood Advances! Deeply appreciative to my mentor Dr. Kline UChicagoCancerCenter and all our collaborators. #lymsm #celltherapy cc CU Lymphoma Program CU Anschutz Division of Hematology ashpublications.org/bloodadvances/…

Our multicenter study of outcomes after checkpoint inhibitor therapy in the post-CAR-T setting is now <a href="/BloodAdvances/">Blood Advances</a>! Deeply appreciative to my mentor Dr. Kline <a href="/UCCancerCenter/">UChicagoCancerCenter</a> and all our collaborators. #lymsm #celltherapy cc <a href="/CULymphoma/">CU Lymphoma Program</a> <a href="/CUHematology/">CU Anschutz Division of Hematology</a> ashpublications.org/bloodadvances/…
ASH (@ash_hematology) 's Twitter Profile Photo

Looking to help lead the next generation of hematologists like Becky Zon, MD? Join the ASH Trainee Council & help create valuable resources & programs for other #heme trainees like YOU! Apply now for 1 of 16 positions (including 4 ✨NEW✨ roles): loom.ly/iMEF2Y4 #ASHTrainee

Anand Patel (@anand_88_patel) 's Twitter Profile Photo

I’ve now had the pleasure of collaborating with all of my ASH CRTI group! Zhuoer (Zoey) Xie, MD, MSCR pubmed.ncbi.nlm.nih.gov/38996210/ Daria Gaut, MD, MSCR pubmed.ncbi.nlm.nih.gov/37801340/ Evan Chen pubmed.ncbi.nlm.nih.gov/38739724/